Cargando…
The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2
The spurious acquisition and optimization of a furin cleavage site in the SARS-CoV-2 spike protein is associated with increased viral transmission and disease, and has generated intense interest in the development and application of therapeutic furin inhibitors to thwart the COVID-19 pandemic. This...
Autores principales: | Thomas, Gary, Couture, Frédéric, Kwiatkowska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999023/ https://www.ncbi.nlm.nih.gov/pubmed/35408793 http://dx.doi.org/10.3390/ijms23073435 |
Ejemplares similares
-
A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2
por: Devi, Kasi Pandima, et al.
Publicado: (2022) -
SARS-CoV-2 spike and its adaptable furin cleavage site
por: Whittaker, Gary R
Publicado: (2021) -
SARS-CoV-2 furin cleavage site was not engineered
por: Garry, Robert F.
Publicado: (2022) -
The SARS-CoV-2 furin cleavage site: natural selection or smoking gun?
por: Lubinski, Bailey, et al.
Publicado: (2023) -
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
por: Essalmani, Rachid, et al.
Publicado: (2022)